Type I error inflation caused by batch-to-batch variability of Reference? [Design Issues]

posted by nobody – 2016-10-20 14:27 (3041 d 02:29 ago) – Posting: # 16742
Views: 8,775

❝ ❝ How would you define "right"?


Right in the sense of: I'm able to show BE (a priori or a posteriori ;-) )


I guess there are two options:

1. The originators' batches are not bioequivalent (or even bioinequivalent), but therapeutically equivalent.

Why should the generic show bioequivalence to more than one batch?

2. The originators' batches are not bioequivalent (or even bioinequivalent) AND are NOT therapeutically equivalent.

Why should such a product be allowed to be marketed?

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,381 posts in 4,914 threads, 1,663 registered users;
46 visitors (0 registered, 46 guests [including 10 identified bots]).
Forum time: 15:57 CET (Europe/Vienna)

Science is built up with facts, as a house is with stones.
But a collection of facts is no more a science
than a heap of stones is a house.    Henri Poincaré

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5